+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Transcatheter Embolization & Occlusion Device Market - Global Forecast 2025-2032

  • PDF Icon

    Report

  • 185 Pages
  • November 2025
  • Region: Global
  • 360iResearch™
  • ID: 5639421
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Senior decision-makers in healthcare are facing a rapidly transforming transcatheter embolization and occlusion device market, shaped by continual technological advancements and evolving care models. Adapting to these changes is critical for sustaining growth, optimizing procurement, and refining clinical and investment strategies.

Market Snapshot: Transcatheter Embolization and Occlusion Device Market

In 2024, the global transcatheter embolization and occlusion device market reached USD 5.94 billion, with expectations to grow to USD 6.73 billion in 2025 and USD 16.03 billion by 2032, reflecting a compound annual growth rate of 13.19%. Growth in this market is driven by increasing reliance on minimally invasive medical procedures and widespread adoption of advanced interventional technology. Healthcare providers worldwide are utilizing these devices across varying clinical applications to improve patient outcomes and streamline operations. The ongoing modernization of healthcare organizations is catalyzing investment realignment and the adoption of next-generation solutions, enabling providers to address shifting standards and expectations within the vascular intervention landscape.

Scope & Segmentation

This report delivers practical segmentation insights, supporting executive teams in making informed decisions related to capital allocation, compliance, procurement planning, and long-term technology investments within the vascular intervention segment.

  • Product Types: Embolization coils, liquid embolic agents, microspheres, particulate agents, and vascular plugs are designed for a wide array of vascular interventions, allowing tailored clinical approaches based on procedural needs.
  • Material Types: Both biological and synthetic materials are used across patient populations, offering versatility and reinforcing adherence to safety protocols throughout various interventions.
  • Technology Platforms: Flow-directed systems, mechanical occlusion devices, and advanced microcatheters expand procedural access, integrating seamlessly into existing workflows and enabling efficient device adoption in diverse clinical environments.
  • Applications: Devices are deployed in hemorrhage management, neurovascular and hepatic procedures, peripheral vasculature treatments, and uterine fibroid therapy, providing solutions for both acute and elective clinical scenarios.
  • End Users: Hospitals, ambulatory surgery centers, and specialty clinics benefit from the adoption of standardized protocols and an adaptable approach, which helps elevate the quality of care within multifaceted organizational structures.
  • Regional Coverage: Comprehensive analysis covers the Americas, Europe, Middle East, Africa, and Asia-Pacific, highlighting the impact of regional regulations, technology adoption rates, and unique care delivery models.
  • Company Coverage: In-depth company profiles feature Boston Scientific Corporation, Medtronic plc, Terumo Corporation, and Johnson & Johnson, giving clarity on competitive strategies and their effects on procurement decisions and technology integration within institutions.

Leveraging segmentation enables stakeholders to target high-value segments, drive innovation responsive to market needs, and align investments to evolving standards and regional nuances in healthcare delivery.

Key Takeaways for Senior Decision-Makers

  • Minimally invasive treatment options are improving workflow efficiencies and enhancing collaboration among providers, supporting safer procedures throughout the care continuum.
  • Ongoing advancements in device engineering are reducing staff training requirements and enabling the widespread use of standardized clinical protocols, leading to faster implementation of new solutions.
  • Integrating advanced imaging modalities and artificial intelligence tools is supporting precise resource planning and enabling more tailored patient care.
  • As the market develops globally, organizations benefit from constructing operating models that can adapt to rapid changes in care delivery expectations and compliance demands.
  • Effective supply chain coordination is increasingly important, as updated regulations and reimbursement frameworks highlight the value of robust partnerships across manufacturing, distribution, and clinical care.

Tariff Impact on the Supply Chain

Recent tariff changes in the United States have disrupted sourcing approaches for essential components, presenting new cost challenges for healthcare systems. Procurement leaders are addressing these shifts by moving toward regionalized production models, diversifying supplier bases, and conducting comprehensive risk assessments to preserve operational resilience and secure reliable device availability.

Methodology & Data Sources

The report’s analysis is built on structured interviews with interventional radiologists and procurement leaders, a thorough literature review, frequent regulatory monitoring, and global trade data analysis. Validation by a multidisciplinary panel ensures that findings and recommendations are credible and actionable for executive management.

Why This Report Matters

  • Provides clarity on regulatory and operational complexities, equipping leadership to guide strategic technology decisions.
  • Delivers actionable recommendations to mitigate supply chain risks and plan for variability in device requirements across regions and specialties.
  • Offers insights on market, regulatory, and technology trends, enabling organizations to sustain operational leadership and adapt effectively to updated standards.

Conclusion

This analysis empowers senior healthcare executives to align their clinical, procurement, and investment decisions, supporting effective adoption of transcatheter embolization and occlusion devices as the healthcare landscape continues to evolve.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Advancements in bioresorbable embolic materials improving long-term vessel patency
5.2. Integration of real-time imaging modalities for enhanced navigation during transcatheter procedures
5.3. Development of shape-memory polymer coils offering controlled occlusion and reduced migration risk
5.4. Expansion of peripheral vascular occlusion applications with novel detachable microcoils
5.5. Emergence of drug-eluting embolic beads targeting tumor vasculature with sustained release kinetics
5.6. Rise of low-profile delivery systems enabling access to distal and tortuous neurovascular anatomy
5.7. Increased adoption of combination therapies coupling embolization with immunotherapy agents
5.8. Regulatory approvals driving growth of next-generation occlusion devices with integrated sensors
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Transcatheter Embolization & Occlusion Device Market, by Product Type
8.1. Embolization Coils
8.1.1. Detachable Coils
8.1.2. Pushable Coils
8.2. Liquid Embolic Agents
8.2.1. Ethylene Vinyl Alcohol Copolymer
8.2.2. N-Butyl Cyanoacrylate
8.3. Microspheres
8.4. Particulate Embolic Agents
8.5. Vascular Plugs
9. Transcatheter Embolization & Occlusion Device Market, by Material
9.1. Biological Agents
9.2. Synthetic Agents
10. Transcatheter Embolization & Occlusion Device Market, by Technology
10.1. Flow Directed Embolization
10.2. Mechanical Occlusion
10.3. Microcatheter Delivery Systems
11. Transcatheter Embolization & Occlusion Device Market, by Application
11.1. Hemorrhage Control
11.2. Hepatic Embolization
11.3. Neurovascular Embolization
11.4. Peripheral Vascular Embolization
11.5. Uterine Fibroid Embolization
12. Transcatheter Embolization & Occlusion Device Market, by End User
12.1. Ambulatory Surgical Centers
12.2. Hospitals
12.3. Specialty Clinics
13. Transcatheter Embolization & Occlusion Device Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Transcatheter Embolization & Occlusion Device Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Transcatheter Embolization & Occlusion Device Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Boston Scientific Corporation
16.3.2. Medtronic plc
16.3.3. Terumo Corporation
16.3.4. Johnson & Johnson
16.3.5. Cook Medical LLC
16.3.6. Merit Medical Systems, Inc.
16.3.7. Penumbra, Inc.
16.3.8. AngioDynamics, Inc.
16.3.9. W. L. Gore & Associates, Inc.
16.3.10. B. Braun Melsungen AG
List of Tables
List of Figures

Companies Mentioned

The companies profiled in this Transcatheter Embolization & Occlusion Device market report include:
  • Boston Scientific Corporation
  • Medtronic PLC
  • Terumo Corporation
  • Johnson & Johnson
  • Cook Medical LLC
  • Merit Medical Systems, Inc.
  • Penumbra, Inc.
  • AngioDynamics, Inc.
  • W. L. Gore & Associates, Inc.
  • B. Braun Melsungen AG

Table Information